Advertisement

Archives of Toxicology

, Volume 83, Issue 8, pp 763–768 | Cite as

Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats

  • Dana Kühnel
  • Felicitas Taugner
  • Bettina Scholtka
  • Pablo SteinbergEmail author
Genotoxicity and Carcinogenicity

Abstract

Heterocyclic aromatic amines (HCAs) are formed in meat cooked at high temperatures for a long time or over an open flame. In this context 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant HCA in cooked meat, has been suggested to be involved in colon and prostate carcinogenesis. In the latter case it has been reported that: (1) roughly 50% of Fischer F344 male rats treated with PhIP develop carcinomas in the ventral prostate lobe at 1 year of age; (2) inflammation precedes prostatic intraepithelial neoplasia in PhIP-fed rats; (3) inflammation specifically occurs in the ventral prostate lobe of PhIP-fed rats. To test whether PhIP by itself leads to inflammation in the colon and whether a human-relevant concentration of PhIP is able to induce preneoplastic lesions in the colon, male F344 rats were fed 0.1 or 100 ppm PhIP for up to 10 months and thereafter the colon tissue was analyzed histochemically. In none of the experimental groups signs of acute or chronic colonic inflammation were observed. 0.1 ppm PhIP leads to the development of hyperplastic and dysplastic lesions in the colon of single animals, but the incidence of these lesions does not reach a statistical significance. In contrast, in rats fed 100 ppm PhIP for 10 months hyperplastic and dysplastic colonic lesions were induced in a statistically significant number of animals. It is concluded that: (1) the induction of preneoplastic lesions in rat colon by PhIP is not preceded or accompanied by an inflammatory process; (2) a human-relevant concentration of PhIP alone is not sufficient to initiate colon carcinogenesis in rats.

Keywords

Colorectal cancer Heterocyclic aromatic amines Inflammation 

Notes

Acknowledgments

We thank Mrs. Ingrid Zschaler for her excellent technical assistance.

References

  1. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen. Preliminary findings. Cancer Lett 37:147–151PubMedCrossRefGoogle Scholar
  2. Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R (2006) Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8:708–715PubMedCrossRefGoogle Scholar
  3. Campana D, Thompson JS, Amlot P, Brown S, Janossy G (1987) The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 138:648–655PubMedGoogle Scholar
  4. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, Rodriguez C, Sinha R, Calle EE (2005) Meat consumption and risk of colorectal cancer. J Am Med Assoc 293:172–182CrossRefGoogle Scholar
  5. Davis CD, Farb A, Thorgeirsson SS, Virmani R, Snyderwine EG (1994) Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. Toxicol Appl Pharmacol 124:201–211PubMedCrossRefGoogle Scholar
  6. Dingley KH, Curtis KD, Nowell S, Felton JS, Lang NP, Turteltaub KW (1999) DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Cancer Epidemiol Biomarkers Prev 8:507–512PubMedGoogle Scholar
  7. Doi K, Wanibuchi H, Salim EI, Morimura K, Kinoshita A, Kudoh S, Hirata K, Yoshikawa J, Fukushima S (2005) Lack of large intestinal carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine at low doses in rats initiated with azoxymethane. Int J Cancer 115:870–878PubMedCrossRefGoogle Scholar
  8. Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 6:482–494CrossRefGoogle Scholar
  9. Friesen MD, Kaderlik RK, Lin DX, Garren L, Bartsch H, Lang NP, Kadlubar FF (1994) Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/negative ion chemical ionization mass spectrometry: validation by comparison with 32P-postlabelling. Chem Res Toxicol 7:733–739PubMedCrossRefGoogle Scholar
  10. Fujiwara K, Ochiai M, Ohta T, Ohki M, Aburatani H, Nagao M, Sugimura T, Nakagama H (2004) Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo [4, 5-b]pyridine. Carcinogenesis 25:1495–1505PubMedCrossRefGoogle Scholar
  11. Fukushima S, Wanibuchi H, Morimura K, Iwai S, Nakae D, Kishida H, Tsuda H, Uehara N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F (2004) Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Toxicol Sci 80:109–114PubMedCrossRefGoogle Scholar
  12. Hasegawa R, Sano M, Tamano S, Imaida K, Shirai T, Nagao M, Sugimura T, Ito N (1993) Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis 14:2553–2557PubMedCrossRefGoogle Scholar
  13. Higaki S, Akazawa A, Nakamura H, Yanai H, Yoshida T, Okita K (1999) Metaplastic polyp of the colon develops in response to inflammation. J Gastroenterol Hepatol 14:709–714PubMedCrossRefGoogle Scholar
  14. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Carcinogenesis 12:1503–1506PubMedCrossRefGoogle Scholar
  15. Itzkowitz SH, Yio X (2004) Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol 287:G7–G17CrossRefGoogle Scholar
  16. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16:39–52PubMedCrossRefGoogle Scholar
  17. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458–3464PubMedGoogle Scholar
  18. Nakagama H, Ochiai M, Ubagai T, Tajima R, Fujiwara K, Sugimura T, Nagao M (2002) A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo [4, 5-b]pyridine, PhIP. Mutat Res 506–507:137–144PubMedGoogle Scholar
  19. Nakai Y, Nelson WG, De Marzo AM (2007) The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 67:1378–1384PubMedCrossRefGoogle Scholar
  20. Nakanishi M, Tazawa H, Tsuchiya N, Sugimura T, Tanaka T, Nakagama H (2007) Mouse strain differences in inflammatory responses of colonic mucosa induced by dextran sulfate sodium cause differential susceptibility to PhIP-induced large bowel carcinogenesis. Cancer Sci 98:1157–1163PubMedCrossRefGoogle Scholar
  21. Nishikawa A, Imazawa T, Kuroiwa Y, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M (2005) Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment. Toxicol Sci 84:243–248PubMedCrossRefGoogle Scholar
  22. Norat T, Lukanova A, Ferrari P, Riboli E (2002) Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 98:241–256PubMedCrossRefGoogle Scholar
  23. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, Overvad K, Olsen A, Tjønneland A, Clavel F, Boutron-Ruault MC, Kesse E, Boeing H, Bergmann MM, Nieters A, Linseisen J, Trichopoulou A, Trichopoulos D, Tountas Y, Berrino F, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Engeset D, Lund E, Skeie G, Ardanaz E, González C, Navarro C, Quirós JR, Sanchez MJ, Berglund G, Mattisson I, Hallmans G, Palmqvist R, Day NE, Khaw KT, Key TJ, San Joaquin M, Hémon B, Saracci R, Kaaks R, Riboli E (2005) Meat, fish and colorectal cancer risk: the European prospective investigation into cancer and nutrition. J Natl Cancer Inst 97:906–916PubMedCrossRefGoogle Scholar
  24. Ochiai M, Ushigome M, Fujiwara K, Ubagai T, Kawamori T, Sugimura T, Nagao M, Nakgama H (2003) Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Am J Pathol 163:1607–1614PubMedGoogle Scholar
  25. Rhodes JM, Campbell BJ (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8:10–16PubMedCrossRefGoogle Scholar
  26. Scheppach W, Bingham S, Boutron-Ruault MC, Gerhardsson de Verdier M, Moreno V, Nagengast FM, Reifen R, Riboli E, Seitz HK, Wahrendorf J (1999) WHO consensus statement on the role of nutrition in colorectal cancer. Eur J Cancer Prev 8:57–62PubMedCrossRefGoogle Scholar
  27. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T, Ito N (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 57:195–198PubMedGoogle Scholar
  28. Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, Rothman N, Hayes RB (2005) Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 65:8034–8041PubMedCrossRefGoogle Scholar
  29. Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, Wakabayashi K (2005) Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine and dextran sodium sulfate in male ICR mice possess β-catenin gene mutations and increases immunoreactivity for β-catenin, cyclooxygenase-2 and inducible nitric oxide synthase. Carcinogenesis 26:229–238PubMedCrossRefGoogle Scholar
  30. Thompson LH, Tucker JD, Stewart SA, Christensen ML, Salazar EP, Carrano AV, Felton JS (1987) Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus Salmonella mutagenicity. Mutagenesis 2:483–487PubMedCrossRefGoogle Scholar
  31. Tudek B, Bird RP, Bruce WR (1989) Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 49:1236–1240PubMedGoogle Scholar
  32. van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, Beijnen JH, Schinkel AH (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo [4, 5-b]pyridine. Cancer Res 63:6447–6452PubMedGoogle Scholar
  33. Wakabayashi K, Nagao M, Esumi H, Sugimura T (1992) Food-derived mutagens and carcinogens. Cancer Res 52:2092S–2098SPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Dana Kühnel
    • 1
    • 2
  • Felicitas Taugner
    • 3
  • Bettina Scholtka
    • 1
  • Pablo Steinberg
    • 1
    • 4
    Email author
  1. 1.Chair of Nutritional Toxicology, Institute of Nutritional ScienceUniversity of PotsdamNuthetalGermany
  2. 2.Department of Cell ToxicologyHelmholtz Centre for Environmental Research UFZLeipzigGermany
  3. 3.Fraunhofer Institute for Toxicology and Experimental MedicineHannoverGermany
  4. 4.Institute for Food Toxicology and Analytical ChemistryUniversity of Veterinary Medicine HannoverHannoverGermany

Personalised recommendations